TRDA insider filings

Entrada Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-09. Screen TRDA transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 12 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
MPM BIOVENTURES 2018, L.P. — 10% owner & MPM BioVentures 2018 LLC — 10% owner & MPM BioVentures 2018 GP LLC — 10% owner4—12 legs · 495,947 sh · $3,600,470—
MPM BioVentures 2014, L.P. — 10% owner & EVNIN LUKE — 10% owner & GADICKE ANSBERT — 10% owner & Foley Todd — 10% owner & MPM BioVentures 2014 (B), L.P. — 10% owner & MPM Asset Management Investors BV2014 LLC — 10% owner & MPM BioVentures 2014 LLC — 10% owner & MPM BioVentures 2014 GP LLC — 10% owner & MPM BIOVENTURES 2018 (B), L.P. — 10% owner & MPM ASSET MANAGEMENT INVESTORS BV2018 LLC — 10% owner4—12 legs · 495,947 sh · $3,600,470—
Doshi Dipal — CEO, Director1——1
Dowden Nathan J — President & COO1——1
Sethuraman Natarajan — President, Research & Develop.1——1
WENTWORTH KORY JAMES — Chief Financial Officer1——1

Recent insider filings — Entrada Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-09-094MPM BioVentures 2014, L.P. — 10% owner
EVNIN LUKE — 10% owner
GADICKE ANSBERT — 10% owner
Foley Todd — 10% owner
MPM BioVentures 2014 (B), L.P. — 10% owner
MPM Asset Management Investors BV2014 LLC — 10% owner
MPM BioVentures 2014 LLC — 10% owner
MPM BioVentures 2014 GP LLC — 10% owner
MPM BIOVENTURES 2018 (B), L.P. — 10% owner
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC — 10% owner
Sale (S): 38,500 @ $7.11 · Sale (S): 192,500 @ $7.41 · Sale (S): 28,837 @ $7.13EDGAR
2026-09-094MPM BIOVENTURES 2018, L.P. — 10% owner
MPM BioVentures 2018 LLC — 10% owner
MPM BioVentures 2018 GP LLC — 10% owner
Sale (S): 38,500 @ $7.11 · Sale (S): 192,500 @ $7.41 · Sale (S): 28,837 @ $7.13EDGAR
2026-09-034WENTWORTH KORY JAMES — Chief Financial OfficerTax withholding (F): 1,733 @ $7.14EDGAR
2026-09-034MPM BIOVENTURES 2018, L.P. — 10% owner
MPM BioVentures 2018 LLC — 10% owner
MPM BioVentures 2018 GP LLC — 10% owner
Sale (S): 29,088 @ $7.06 · Sale (S): 25,131 @ $7.19 · Sale (S): 32,263 @ $7.17EDGAR
2026-09-034MPM BioVentures 2014, L.P. — 10% owner
EVNIN LUKE — 10% owner
GADICKE ANSBERT — 10% owner
Foley Todd — 10% owner
MPM BioVentures 2014 (B), L.P. — 10% owner
MPM Asset Management Investors BV2014 LLC — 10% owner
MPM BioVentures 2014 LLC — 10% owner
MPM BioVentures 2014 GP LLC — 10% owner
MPM BIOVENTURES 2018 (B), L.P. — 10% owner
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC — 10% owner
Sale (S): 29,088 @ $7.06 · Sale (S): 25,131 @ $7.19 · Sale (S): 32,263 @ $7.17EDGAR
2026-09-034Dowden Nathan J — President & COOTax withholding (F): 2,528 @ $7.14EDGAR
2026-09-034Doshi Dipal — CEO, DirectorTax withholding (F): 8,724 @ $7.14EDGAR
2026-09-034Sethuraman Natarajan — President, Research & Develop.Tax withholding (F): 2,079 @ $7.14EDGAR
2026-08-314MPM BIOVENTURES 2018, L.P. — 10% owner
MPM BioVentures 2018 LLC — 10% owner
MPM BioVentures 2018 GP LLC — 10% owner
Sale (S): 38,922 @ $7.20 · Sale (S): 3,733 @ $7.01 · Sale (S): 44,259 @ $6.99EDGAR
2026-08-314MPM BioVentures 2014, L.P. — 10% owner
EVNIN LUKE — 10% owner
GADICKE ANSBERT — 10% owner
Foley Todd — 10% owner
MPM BioVentures 2014 (B), L.P. — 10% owner
MPM Asset Management Investors BV2014 LLC — 10% owner
MPM BioVentures 2014 LLC — 10% owner
MPM BioVentures 2014 GP LLC — 10% owner
MPM BIOVENTURES 2018 (B), L.P. — 10% owner
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC — 10% owner
Sale (S): 38,922 @ $7.20 · Sale (S): 3,733 @ $7.01 · Sale (S): 44,259 @ $6.99EDGAR
2026-08-264MPM BIOVENTURES 2018, L.P. — 10% owner
MPM BioVentures 2018 LLC — 10% owner
MPM BioVentures 2018 GP LLC — 10% owner
Sale (S): 21,623 @ $7.34 · Sale (S): 26,522 @ $7.54 · Sale (S): 14,569 @ $7.06EDGAR
2026-08-264MPM BioVentures 2014, L.P. — 10% owner
EVNIN LUKE — 10% owner
GADICKE ANSBERT — 10% owner
Foley Todd — 10% owner
MPM BioVentures 2014 (B), L.P. — 10% owner
MPM Asset Management Investors BV2014 LLC — 10% owner
MPM BioVentures 2014 LLC — 10% owner
MPM BioVentures 2014 GP LLC — 10% owner
MPM BIOVENTURES 2018 (B), L.P. — 10% owner
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC — 10% owner
Sale (S): 21,623 @ $7.34 · Sale (S): 26,522 @ $7.54 · Sale (S): 14,569 @ $7.06EDGAR
2026-08-104PARMAR KUSH — DirectorSale (S): 10,494 @ $7 · Sale (S): 52,317 @ $6.85 · Sale (S): 92,444 @ $7EDGAR
2026-08-1045AM Ventures V, L.P. — 10% owner
5AM Partners V, LLC — 10% owner
5AM Opportunities I, L.P. — 10% owner
5AM Opportunities I (GP), LLC — 10% owner
ROCKLAGE SCOTT M — 10% owner
Schwab Andrew J. — 10% owner
Sale (S): 10,494 @ $7 · Sale (S): 52,317 @ $6.85EDGAR
2026-08-0345AM Ventures V, L.P. — 10% owner
5AM Partners V, LLC — 10% owner
5AM Opportunities I, L.P. — 10% owner
5AM Opportunities I (GP), LLC — 10% owner
ROCKLAGE SCOTT M — 10% owner
Schwab Andrew J. — 10% owner
Sale (S): 114,756 @ $6.93 · Sale (S): 1,718 @ $6.85EDGAR
2026-08-034PARMAR KUSH — Director, 10% ownerSale (S): 114,756 @ $6.93 · Sale (S): 1,718 @ $6.85EDGAR
2026-06-124Radhakrishnan Maha — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2026-06-124Chapman Gina — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2026-06-124Zeiher Bernhardt G — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2026-06-124PARMAR KUSH — Director, 10% ownerGrant/award (A): 19,000 (derivative) @ $0EDGAR
2026-06-124Thistle Mary — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2026-06-124KIM PETER S — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2026-05-214Zeiher Bernhardt G — DirectorPurchase (P): 5,000 @ $5.86EDGAR
2026-05-044Sethuraman Natarajan — President, Research & Develop.Sale (S): 25,907 @ $15.39EDGAR
2026-05-044Dowden Nathan J — President & COOOption exercise (M): 15,000 @ $1.74 · Sale (S): 15,000 @ $15.33 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-04-024WENTWORTH KORY JAMES — Chief Financial OfficerSale (S): 2,500 @ $12.95EDGAR
2026-03-114Dowden Nathan J — President & COOSale (S): 3,116 @ $13.02 · Sale (S): 11,894 @ $13.05EDGAR
2026-03-114WENTWORTH KORY JAMES — Chief Financial OfficerSale (S): 5,089 @ $13.00 · Sale (S): 11,388 @ $13.02EDGAR
2026-03-064WENTWORTH KORY JAMES — Chief Financial OfficerSale (S): 7,988 @ $12.25EDGAR
2026-03-034Sethuraman Natarajan — President, Research & Develop.Grant/award (A): 55,800 @ $0 · Tax withholding (F): 3,898 @ $11.66 · Tax withholding (F): 7,577 @ $11.76 · Grant/award (A): 83,200 (derivative) @ $0EDGAR
2026-03-034Dowden Nathan J — President & COOGrant/award (A): 55,800 @ $0 · Tax withholding (F): 7,223 @ $11.66 · Tax withholding (F): 14,038 @ $11.76 · Grant/award (A): 83,200 (derivative) @ $0EDGAR
2026-03-034WENTWORTH KORY JAMES — Chief Financial OfficerGrant/award (A): 44,600 @ $0 · Tax withholding (F): 2,939 @ $11.66 · Tax withholding (F): 5,712 @ $11.76 · Grant/award (A): 66,600 (derivative) @ $0EDGAR
2026-03-034Doshi Dipal — CEO, DirectorGrant/award (A): 139,400 @ $0 · Tax withholding (F): 9,869 @ $11.66 · Tax withholding (F): 19,181 @ $11.76 · Grant/award (A): 208,000 (derivative) @ $0EDGAR
2025-11-244WENTWORTH KORY JAMES — Chief Financial OfficerSale (S): 8,910 @ $9.98EDGAR
2025-11-244BAKER BROS. ADVISORS LP — 10% owner
Baker Bros. Advisors (GP) LLC — 10% owner
BAKER FELIX — 10% owner
BAKER JULIAN — 10% owner
Purchase (P): 1,213 @ $9.07 · Purchase (P): 13,386 @ $9.07 · Purchase (P): 1,186 @ $9.07 · Purchase (P): 13,082 @ $9.07EDGAR
2025-11-184PARMAR KUSH — Director, 10% ownerSale (S): 200,000 @ $8.80EDGAR
2025-11-1845AM Ventures V, L.P. — 10% owner
5AM Partners V, LLC — 10% owner
5AM Opportunities I, L.P. — 10% owner
5AM Opportunities I (GP), LLC — 10% owner
ROCKLAGE SCOTT M — 10% owner
Schwab Andrew J. — 10% owner
Sale (S): 200,000 @ $8.80EDGAR
2025-11-124BAKER BROS. ADVISORS LP — 10% owner
Baker Bros. Advisors (GP) LLC — 10% owner
BAKER FELIX — 10% owner
BAKER JULIAN — 10% owner
Purchase (P): 2,296 @ $7.21 · Purchase (P): 25,364 @ $7.21 · Purchase (P): 267 @ $7.22 · Purchase (P): 2,947 @ $7.22 · Purchase (P): 1,059 @ $7.39 · Purchase (P): 11,701 @ $7.39 · +6 moreEDGAR
2025-09-044Sethuraman Natarajan — President, Research & Develop.Tax withholding (F): 1,760 @ $5.43EDGAR
2025-09-044Dowden Nathan J — President & COOTax withholding (F): 1,746 @ $5.43EDGAR
2025-09-044WENTWORTH KORY JAMES — Chief Financial OfficerTax withholding (F): 1,734 @ $5.43EDGAR
2025-09-044Doshi Dipal — CEO, DirectorTax withholding (F): 8,723 @ $5.43EDGAR
2025-07-114PARMAR KUSH — Director, 10% ownerSale (S): 20,065 @ $7.50 · Sale (S): 6,935 @ $7.50EDGAR
2025-07-1145AM Ventures V, L.P. — 10% owner
5AM Partners V, LLC — 10% owner
5AM Opportunities I, L.P. — 10% owner
5AM Opportunities I (GP), LLC — 10% owner
ROCKLAGE SCOTT M — 10% owner
Schwab Andrew J. — 10% owner
Sale (S): 20,065 @ $7.50 · Sale (S): 6,935 @ $7.50EDGAR
2025-07-014PARMAR KUSH — Director, 10% ownerSale (S): 55,735 @ $6.91 · Sale (S): 19,265 @ $6.91 · Sale (S): 18,578 @ $6.81 · Sale (S): 6,422 @ $6.81 · Sale (S): 18,578 @ $7.12 · Sale (S): 6,422 @ $7.12EDGAR
2025-07-0145AM Ventures V, L.P. — 10% owner
5AM Partners V, LLC — 10% owner
5AM Opportunities I, L.P. — 10% owner
5AM Opportunities I (GP), LLC — 10% owner
ROCKLAGE SCOTT M — 10% owner
Schwab Andrew J. — 10% owner
Sale (S): 55,735 @ $6.91 · Sale (S): 19,265 @ $6.91 · Sale (S): 18,578 @ $6.81 · Sale (S): 6,422 @ $6.81 · Sale (S): 18,578 @ $7.12 · Sale (S): 6,422 @ $7.12EDGAR
2025-06-184/AKIM PETER S — DirectorPurchase (P): 25,000 @ $14.68 · Purchase (P): 25,000 @ $14.59EDGAR
2025-06-124PARMAR KUSH — Director, 10% ownerGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-06-124Thistle Mary — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR
2025-06-124KIM PETER S — DirectorGrant/award (A): 19,000 (derivative) @ $0EDGAR

Recent 8-K events — Entrada Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-148-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-198-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-268-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-088-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
8.01 — Other Events
EDGAR
2025-11-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TRDA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs